HK-based Horizons Ventures invests $26m in UK's bio-research firm Synthace

HK-based Horizons Ventures invests $26m in UK's bio-research firm Synthace

Photo: Bloomberg

London-based Synthace Ltd, a cloud-based platform that helps improve the success rate of biological research, has closed a $25.6-million Series B financing round led by Hong Kong-based Horizons Ventures, the private investment arm of investor Li Ka-shing, according to an announcement.

Its existing investors, Luminous Ventures, SOSV and others also participated in the round.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter